Ascendis Pharma (spons. ADRs) Aktie
194,00
EUR
-1,00
EUR
-0,51
%
224,95
USD
-3,27
USD
-1,43
%
Werbung
Ascendis Pharma (spons. ADRs) Aktie Analyse
| 24.01.19 | Ascendis Pharma (spons. ADRs) Overweight | Cantor Fitzgerald | |
| 26.06.18 | Ascendis Pharma (spons. ADRs) Buy | Stifel, Nicolaus & Co., Inc. | |
| 26.09.16 | Ascendis Pharma (spons. ADRs) Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung